GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medicalsystem Biotechnology Co Ltd (SZSE:300439) » Definitions » Asset Impairment Charge

Medicalsystem Biotechnology Co (SZSE:300439) Asset Impairment Charge : ¥0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Medicalsystem Biotechnology Co Asset Impairment Charge?

Medicalsystem Biotechnology Co's Asset Impairment Charge for the three months ended in Sep. 2024 was ¥0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0 Mil.


Medicalsystem Biotechnology Co Asset Impairment Charge Historical Data

The historical data trend for Medicalsystem Biotechnology Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicalsystem Biotechnology Co Asset Impairment Charge Chart

Medicalsystem Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medicalsystem Biotechnology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medicalsystem Biotechnology Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.


Medicalsystem Biotechnology Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Medicalsystem Biotechnology Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicalsystem Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 299 Qiming South Road, Yinzhou District, Zhejiang Province, Ningbo City, CHN, 315104
Medicalsystem Biotechnology Co Ltd is engaged in research and development, manufacture and distribution of diagnostic products. It provides in-vitro biochemical diagnostic reagents to healthcare facilities.
Executives
Zou Bing De Director
Xiong Hui Ping Secretary Dong
Zhuo Hong Ye Director
Wu Li Shan Supervisors
Fang Liang Executives
Zou Ji Hua Directors, executives
Wo Yan Bo Executives

Medicalsystem Biotechnology Co Headlines

No Headlines